{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:15:44Z","timestamp":1784754944650,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trre.2026.101003","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:27:22Z","timestamp":1771288042000},"page":"101003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tirzepatide in solid organ transplant recipients: Early real-world signals of efficacy and safety\u2014A narrative review"],"prefix":"10.1016","volume":"40","author":[{"given":"Lucas Maciel de Almeida","family":"Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Rian","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Belo Gamon","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Esteves","family":"Dante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Silva","family":"de Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Beatriz Souza","family":"Ferr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2026.101003_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21st century","volume":"6","author":"Black","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.trre.2026.101003_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endrev\/bnaa030","article-title":"Metabolic consequences of solid organ transplantation","volume":"42","author":"Bhat","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.trre.2026.101003_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.trre.2026.101003_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165712","article-title":"Effect of the obesity epidemic on kidney transplantation: obesity is independent of diabetes as a risk factor for adverse renal transplant outcomes","volume":"11","author":"Kwan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2026.101003_bb0025","series-title":"Endotext [Internet]","article-title":"Diabetes mellitus after solid organ transplantation","author":"Pham","year":"2000"},{"key":"10.1016\/j.trre.2026.101003_bb0030","article-title":"Obesity treatment as a bridge to solid organ transplantation: a comparison of bariatric surgery to medical therapy","volume":"16","author":"Roddy","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.trre.2026.101003_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.trre.2026.101003_bb0160","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.tips.2025.08.013","article-title":"Can GLP-1RAs redefine transplantation standard of care?","volume":"46","author":"Almalki","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trre.2026.101003_bb0060","article-title":"Long-term response to tirzepatide after kidney transplant","author":"Miura","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101003_bb0065","first-page":"12","article-title":"Kidney transplantation: assessment of safety and efficacy of tirzepatide in kidney transplant patients\u2014experience of a quaternary care center in the Middle East","volume":"23","author":"El Khatib","year":"2025","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2026.101003_bb0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/ds24-0071","article-title":"Safety and effectiveness of tirzepatide in solid-organ transplant recipients","volume":"38","author":"Sweiss","year":"2025","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.trre.2026.101003_bb0075","doi-asserted-by":"crossref","DOI":"10.2337\/db24-13-PUB","article-title":"Safety and efficacy of tirzepatide in patients with solid-organ transplant","volume":"73","author":"Dowlatshahi","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.trre.2026.101003_bb0150","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1016\/j.ajt.2025.07.915","article-title":"Tolerability and effectiveness of Tirzepatide in kidney transplant recipients: real world experience from a single center study","volume":"25","author":"Lim","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101003_bb0155","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf149.1155","article-title":"Treatment of prediabetes and obesity with Tirzepatide in a patient with history of type 1 diabetes with pancreas and kidney transplant","volume":"9","author":"Liu","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.trre.2026.101003_bb0095","article-title":"Safety and efficacy of semaglutide in post kidney transplant patients with type 2 diabetes or post-transplant diabetes","volume":"36","author":"Mahzari","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.trre.2026.101003_bb0115","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/TP.0000000000004945","article-title":"Glucagon-like peptide 1 receptor agonists and cardiovascular outcomes in solid organ transplant recipients with diabetes mellitus","volume":"108","author":"Dotan","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101003_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae018","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis","volume":"17","author":"Krisanapan","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.trre.2026.101003_bb0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.23876\/j.krcp.24.271","article-title":"Safety and efficacy of glucagon-like peptide 1 receptor agonists in solid organ transplant recipients with diabetes mellitus: a systematic review and meta-analysis","volume":"44","author":"Usman","year":"2025","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.trre.2026.101003_bb0045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s13300-020-00786-1","article-title":"A retrospective study of glucagon-like peptide 1 receptor agonists for the management of diabetes after transplantation","volume":"11","author":"Thangavelu","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.trre.2026.101003_bb0050","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"STEP 4 investigators. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2026.101003_bb0055","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1111\/dom.70143","article-title":"Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: a post hoc analysis from the three-year SURMOUNT-1 trial","volume":"27","author":"Hankosky","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.trre.2026.101003_bb0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13300-020-00790-5","article-title":"Post-transplantation diabetes mellitus","volume":"11","author":"Ahmed","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.trre.2026.101003_bb0145","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2010.03330.x","article-title":"Body mass index, waist circumference and mortality in kidney transplant recipients","volume":"10","author":"Kovesdy","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101003_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15401","article-title":"Cardio-renal-metabolic outcomes associated with the use of GLP-1 receptor agonists after heart transplantation","volume":"38","author":"Donald","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2026.101003_bb0120","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0001037004.02896.90","article-title":"Association of glucagon-like peptide-1 therapies and risk of cancer in liver transplant patients","volume":"119","author":"Faisal","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trre.2026.101003_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70246","article-title":"Impact of GLP-1 and GLP-1\/GIP receptor agonist weight loss post-lung transplant on lung allograft function","volume":"39","author":"January","year":"2025","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2026.101003_bb0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.transproceed.2024.11.016","article-title":"Tolerability and effectiveness of glucagon-like peptide-1 receptor agonists in lung transplant recipients: a single center report","volume":"57","author":"Fishman","year":"2025","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101003_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101003_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2026.101003_bb0090","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2213-8587(22)00243-1","article-title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes (SURPASS-4): post hoc analysis of a randomised, open-label, phase 3 trial","volume":"10","author":"Heerspink","year":"2022","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:00:17Z","timestamp":1773050417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X26000133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0955470X26000133"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2026.101003","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide in solid organ transplant recipients: Early real-world signals of efficacy and safety\u2014A narrative review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2026.101003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101003"}}